Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
PerkinElmer
(NY:
PKI
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EDT, May 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PerkinElmer
< Previous
1
2
3
4
5
6
Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
November 28, 2022
Via
Benzinga
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
November 21, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
November 14, 2022
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer Clocks Lower Quarterly Earnings, But Beat Expectations
November 08, 2022
Via
Benzinga
PerkinElmer to Present at 2022 Stifel Healthcare Conference
November 10, 2022
From
PerkinElmer Inc.
Via
Business Wire
PerkinElmer Announces Financial Results for the Third Quarter of 2022
November 08, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report
November 07, 2022
From
PerkinElmer Inc.
Via
Business Wire
Analyst Ratings for PerkinElmer
October 06, 2022
PerkinElmer (NYSE:PKI) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Analyst Ratings for PerkinElmer
September 12, 2022
Analysts have provided the following ratings for PerkinElmer (NYSE:PKI) within the last quarter:
Via
Benzinga
Expert Ratings for PerkinElmer
August 02, 2022
Analysts have provided the following ratings for PerkinElmer (NYSE:PKI) within the last quarter:
Via
Benzinga
PerkinElmer Board Declares Quarterly Dividend
October 26, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Sweetens Its Outlook And Shares Surge, But There's Still One Hitch
October 17, 2022
The company now expects several parameters to come in above initial forecasts.
Via
Investor's Business Daily
PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
October 17, 2022
From
PerkinElmer, Inc.
Via
Business Wire
PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
October 13, 2022
From
PerkinElmer Inc.
Via
Business Wire
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via
Benzinga
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
September 26, 2022
From
PerkinElmer, Inc.
Via
Business Wire
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
September 22, 2022
From
PerkinElmer
Via
Business Wire
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
September 07, 2022
On Wednesday, 297 companies achieved new lows for the year.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Upgrades
Via
Benzinga
PerkinElmer to Present at Upcoming Investor Conferences
August 24, 2022
From
PerkinElmer Inc.
Via
Business Wire
What 7 Analyst Ratings Have To Say About PerkinElmer
August 18, 2022
Analysts have provided the following ratings for PerkinElmer (NYSE:PKI) within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2022
August 18, 2022
Via
Benzinga
Former PerkinElmer Executive Joins Moderna As Finance Chief
August 17, 2022
Via
Benzinga
PerkinElmer Announces Finance Leadership Transition
August 17, 2022
From
PerkinElmer, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
August 02, 2022
Upgrades
Via
Benzinga
Pearson, Nikola And Some Other Big Gainers From Monday
August 02, 2022
U.S. stocks closed slightly lower on Monday, with the Nasdaq Composite dropping around 02%. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
August 02, 2022
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
Via
Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
August 01, 2022
Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.